Abstract
Vasculogenesis, angiogenesis, and arteriogenesis are terms used to describe the formation of blood vessels. Embryonic neovascularization by vasculogenesis refers to the formation of primitive blood vessels inside the embryo and its surrounding membranes and involves the in situ differentiation of mesoderm-derived angioblasts, which aggregate and form de novo blood vessels. Vascularization of the brain occurs primarily through angiogenesis. Angiogenesis involves the formation of new blood vessels via sprouting or splitting from pre-existing vessels and occurs both pre- and postnatally. Arteriogenesis refers to the enlargement of pre-existing collateral arterioles to form larger arteries. Specific angiogenic factor signaling systems choreograph each step of blood vessel formation. Vasculogenesis and angiogenesis are not exclusive processes but instead constitute complementary mechanisms for postnatal neovascularization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Flamme IRW. Induction of vasculogenesis and hematopoiesis in vitro. Development 1992;116:435–439.
Asahara TAK. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004;287:C575–C579.
Poole TFEB, Cox CM. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn 2001;220:1–17.
Yamashita JIH, Hirashima M, Ogawa M, et al. Flk-1 positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408:92–96.
Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation growth and remodeling. J Neuro-Oncol 2000;50:1–15.
Gault JS, Sarin H, Nabil A, Shenkar R, Awad I. Pathobiology of Human Cerebrovascular Malformations: Basic Mechanisms and Clinical Relevance. Neurosurgery 2004;55(l):1–20.
Yamada S, ed. Arteriovenous Malformations in Functional Areas of the Brain. Armonk, NY: Futura Publishing, 1999.
Wang HC, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998;93:741–753.
Pardanaud LY, Yassine F, Dieterlen-Lievre F. Relationship between vasculogenesis, angiogenesis, and haematopoiesis during avian ontogeny. Development 1989;105:473–485.
D’Angelo MA, Afanasieva T, Aguzzi A. Angiogenesis in transgenic models of multistep carcinogenesis. J Neuro-Oncol 2000;50:89–98.
Kurz H. Physiology of angiogenesis. J Neuro-Oncol 2000;50:17–35.
Marin-Padilla M. Early vascularization of the embryonic cerebral cortex: Colgi and electron microscopic studies. J Comp Neurol 1985;241:237–249.
Strong L. The early embryonic pattern of internal vascularization of the mammalian cerebral cortex. J Comp Neurol 1964;123:121–138.
Webb CVWG. Genes that regulate metastasis and angiogenesis. J Neuro-Oncol 2000;50:71–87.
Ferrara N. Vascular endothelial growth factor and the regulation of vascular angiogenesis. Recent Prog Horm Res 2000;55:15–36.
Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001;280:C1358–C1366.
Yancopoulus GS, Davis S, Gale NW, Rudge JS. Vascular specific growth factors and blood vessel formation. Nature 2000;407:242–248.
Lopes M. Angiogenesis in brain tumors. Microsc Res Tech 2003;60:225–230.
Damert AM, Machein M, Breier G, et al. Upregulation of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas. Neuropathol Appl Neurobiol 1997;24:29–35.
Harrigan M. Angiogenic factors in the central nervous system. Neurosurgery 2003;53(3):1–23.
Jansen M, de Witt Hamer PC, Witmer AN, Troost D, van Noorden CJ. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Rev 2004;45:143–163.
Damert AM, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, Plate KH. Upregulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 1997;57:3860–3864.
Ikeda E, Achen MG, Brier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;270:19,761–19,766.
Plate KB, Brier G, Welch H, Mennel H, Risau W. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 1994;59:520–529.
Wang DH, Su Huang HJ, Kazlauskas A, Cavence WK. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phyosphatidylinositol 3-kinase. Cancer Res 1999;59:11,464–11,472.
Sanchea-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L, Bernabeu C. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human endothelial growth factor gene expression. J Biol Chem 2001;276:38,527–38,535.
Chiarugi V. Molecular polarity in endothelial cells and tumor-induced angiogenesis. Oncol Res 2000;12:1–4.
Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occludens. J Biol Chem 1999;274:23,463–23,467.
Jones N, Iljin K, Dumont DJ, Alitalo K. Tie receptors: New modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2001;2:257–267.
Maisonpierre PS, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55–60.
Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 2002;99(17):11,205–11,210.
Visconti RR, Richardson CD, Sato TN. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor. Proc Natl Acad Sci 2002;99:8219–8224.
Loughna S, Sato TN. A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis. Mol Cell 2001;7:233–239.
Sato TN, Tozawa Y, Deutsch U. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70–74.
Beck H, Acker T, Wiessner C, Allegrini P, Plate K. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am J Pathol 2000;157:1473–1483.
Breier G, Blum S, Peli J. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis. Int J Cancer 1976;97:142–148.
Ingber D. Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis. J Cell Biochem 1991;47:236–241.
Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction betwteen embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998;93:741–753.
Friedlander MB, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct alpha V integrins. Scin 1995;270:1500–1502.
Robertson PL, Du Bois M, Bowman PD, Goldstein GW. An in vivo and in vitro study. Brain Res 1985;355:219–223.
Hobson B, Denekamp J. Endothelial proliferation in tumors and normal tissues: continuous labeling studies. Br J Cancer 1984;49:405–413.
D’Angelo MG, Afanasieva T, Aguzzi A. Angiogenesis in transgenic models of multistep carcinogenesis. J Neuro-Oncol 2000;50:89–98.
Takahashi T, Kalka C, Masuda H, et al. Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434–438.
Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389–395.
Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide financial hemangioblast activity during retinal neovascularization. Nat Med 2002;8:607–612.
Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995;333:283–287.
Crosby JR, Kaminski WE, Schatteman G, et al. Endothelial cells of hematopoietic origin make a significant contricution to adult blood vessel formation. Circ Res 2000;87:728–730.
Ashara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–967.
Ashara T, Masuda H, Takahashi T. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221–228.
Davidoff AM, Ng CY, Brown P, et al. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 2001;7:2870–2879.
Lyden D, Hattori K, Dias S. Impaired recruitment of bone-marrow derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194–1201.
Chao M. Neurotrophins and their receptors: a convergence point for many signaling pathways. Nat Rev Neurosci 2003;4:299–309.
Lin TN, Wang CK, Cheung WM, Hsu CY. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2000;20:387–395.
Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A herparin-binding angiogenic protein-basic fibroblast growth factor is stored with basement membrane. Am J Pathol 1998;130:393–400.
Machein MR, Plate KH. VEGF in brain tumors. J Neuro-Oncol 2000;50:109–150.
Plate KH, Breir G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 1992;359:845–847.
Berkman RA, Merrill MJ, Reinhold WC. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993;91:153–159.
Criscuolo GR, Balledux JP. Clinical neurosciences in the decade of the brain: Hypotheses in neuro-oncology-VEG/PF acts upon the actin cytoskeleton and is inhibited by dexamethasone: Relevance to tumor angiogenesis and vasogenic edema. Yale J Biol Med 1996;69:337–355.
Ding H, Roncari L, Wu X, Shannon P, Naggy A, Guha A. Expression and hypoxic regulation of angiopoietins in human astrocytomas. Neurooncology 2001;3:1–10.
Audero E, Cascone I, Zanon I, et al. Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis in vivo and in vitro studies. Arterioscler Thromb Vase Biol 2001;21:536–541.
Marchuk DA, Srinivasan S, Squire TL, Zawistowki JS. Vascular morphogenesis: tales of two syndromes. Hum Mol Genet R 2003;12:97–112.
Kirsch M, Schackert G, Black PM. Angiogenesis, metastasis, and endogenous inhibition. J Neuro-Oncol 2000;41(2)173–180.
Puduvalli VK, Sawaya R. Antiangiogenesis—therapeutic strategies and clinical implications for brain tumors. J Neuro-Oncol 2000;50(l,2):189–200.
Puduvalli VK. Inhibition of angiogenesis as a therapeutic strategy against brain tumors. Cancer Treat Res 2004;117:307–336.
Millauer BS, Shawver LK, Plate KH, Risau W. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994;367:576–579.
Short SC, Traish D, Dowe A, Hines F, Gore M, Brada M. Thalidomide as an anti-angiogenic agent in relapsed gliomas. J Neuro-Oncol 2001;51:41–45.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Grant, G.A., Janigro, D. (2006). Vasculogenesis and Angiogenesis. In: Janigro, D. (eds) The Cell Cycle in the Central Nervous System. Contemporary Neuroscience. Humana Press. https://doi.org/10.1007/978-1-59745-021-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-59745-021-8_4
Publisher Name: Humana Press
Print ISBN: 978-1-58829-529-3
Online ISBN: 978-1-59745-021-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)